<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR59">
 <label>59.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ledgerwood</surname>
    <given-names>JE</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>CJ</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Gordon</surname>
    <given-names>IJ</given-names>
   </name>
   <name>
    <surname>Enama</surname>
    <given-names>ME</given-names>
   </name>
   <name>
    <surname>Hendel</surname>
    <given-names>CS</given-names>
   </name>
   <name>
    <surname>McTamney</surname>
    <given-names>PM</given-names>
   </name>
   <name>
    <surname>Pearce</surname>
    <given-names>MB</given-names>
   </name>
   <name>
    <surname>Yassine</surname>
    <given-names>HM</given-names>
   </name>
   <name>
    <surname>Boyington</surname>
    <given-names>JC</given-names>
   </name>
   <name>
    <surname>Bailer</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Tumpey</surname>
    <given-names>TM</given-names>
   </name>
   <name>
    <surname>Koup</surname>
    <given-names>RA</given-names>
   </name>
   <name>
    <surname>Mascola</surname>
    <given-names>JR</given-names>
   </name>
   <name>
    <surname>Nabel</surname>
    <given-names>GJ</given-names>
   </name>
   <name>
    <surname>Graham</surname>
    <given-names>BS</given-names>
   </name>
  </person-group>
  <article-title>VRC 306 Study Team. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials</article-title>
  <source>Lancet Infect Dis</source>
  <year>2011</year>
  <volume>11</volume>
  <issue>12</issue>
  <fpage>916</fpage>
  <lpage>924</lpage>
  <pub-id pub-id-type="doi">10.1016/S1473-3099(11)70240-7</pub-id>
  <?supplied-pmid 21975270?>
  <pub-id pub-id-type="pmid">21975270</pub-id>
 </element-citation>
</ref>
